FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the chemical-pharmaceutical industry and represents a composition in the form of a gelatine capsule possessing the antihypertensive action, containing lisinopril dihydrate granules and verapamil hydrochloride tablets in a ratio of 1:5 to 1:20.
EFFECT: invention refers to a method for preparing this composition, consisting in encasing the lisinopril granules and verapamil tablets into the gelatine capsule that provides the ease of preparing the dosage form, and an acceptable profile of the therapeutic substance release.
2 cl, 2 ex, 4 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED ANTIHYPERTENSIVE DRUG AND METHOD FOR PREPARING IT | 2011 |
|
RU2483728C1 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
| ORAL PHARMACEUTICAL COMPOSITION OF DIURETICS AND ACE INHIBITOR IN MICRONIZED FORM, DRUG AND ITS APPLICATION | 2012 |
|
RU2618471C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES | 2011 |
|
RU2491070C2 |
| STABLE PHARMACEUTICAL COMPOSITION OF ANTIHYPERTENSIVE ACTION | 2007 |
|
RU2341254C1 |
| CAPSULE AND DRUG PREPARATION FOR PREVENTING CARDIOVASCULAR DISEASES | 2009 |
|
RU2477123C2 |
| FORM OF PROLONGED VENLAFAXINE HYDROCHLORIDE LIBERATION | 2004 |
|
RU2340331C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND ACE INHIBITOR | 2016 |
|
RU2750934C2 |
| HYPOTENSIVE MEANS | 2014 |
|
RU2554815C1 |
| STABLE PHARMACEUTICAL PREPARATION CONTAINING AMLODIPINE BENZYLATE AND ATENOLOL | 1998 |
|
RU2188636C2 |
